This means patients get the most current and comprehensive medical advice available
If you do choose to combine these methods, make sure to stay hydrated and fill your diet with nutrient-dense whole foods in between fasts
In a recent study, these novel, long-acting triple receptor agonist formulations more effectively and successfully reduced weight in obese mouse models compared to semaglutide, tirzepatide, dual GLP-1/glucagon receptor agonists, or short-acting triple receptor agonists, and their use did not entail increased risk of hypoglycemia [104]
Semaglutide has FDA approval for weight management at higher doses (Wegovy 2.4mg weekly), while tirzepatide currently only treats diabetes at doses ranging from 2.5-15mg weekly
Your name, address and postcode were passed securely to Paragon Customer Communications Ltd who will not use this personal data for any other purpose and will delete the data within 30 days of sending this invitation letter
You're Eating Less but Not Eating Enough Protein GLP-1 medications reduce appetite, which can make it difficult to consume adequate protein